RIVA, CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 5.087
EU - Europa 4.352
AS - Asia 871
Continente sconosciuto - Info sul continente non disponibili 13
SA - Sud America 10
OC - Oceania 4
AF - Africa 2
Totale 10.339
Nazione #
US - Stati Uniti d'America 5.077
IT - Italia 2.255
UA - Ucraina 794
TR - Turchia 372
SE - Svezia 345
CN - Cina 252
DE - Germania 236
VN - Vietnam 225
IE - Irlanda 211
FI - Finlandia 195
FR - Francia 139
GB - Regno Unito 98
BE - Belgio 17
RU - Federazione Russa 16
NL - Olanda 15
EU - Europa 13
IN - India 11
CA - Canada 9
BR - Brasile 6
PL - Polonia 5
DK - Danimarca 4
AU - Australia 3
CH - Svizzera 3
CO - Colombia 3
HR - Croazia 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
EG - Egitto 2
JP - Giappone 2
LU - Lussemburgo 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
BO - Bolivia 1
BT - Bhutan 1
CZ - Repubblica Ceca 1
ES - Italia 1
GR - Grecia 1
HU - Ungheria 1
ID - Indonesia 1
IS - Islanda 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
RO - Romania 1
SG - Singapore 1
TW - Taiwan 1
Totale 10.339
Città #
Milan 1.616
Chandler 609
Jacksonville 607
Fairfield 578
Woodbridge 388
Dearborn 317
Ann Arbor 280
Ashburn 278
Wilmington 250
Houston 248
Princeton 218
Dublin 209
Seattle 201
Izmir 189
Nyköping 188
Cambridge 171
Rome 113
Dong Ket 110
San Mateo 88
Beijing 72
Como 71
New York 56
San Diego 50
Ogden 43
Hefei 26
Kunming 19
Nanjing 17
Guangzhou 15
Verona 15
Brussels 14
Jinan 14
London 13
Norwalk 13
Düsseldorf 12
Nanchang 12
Boardman 10
Washington 10
Casorezzo 7
Catania 7
Fuzhou 7
Pune 7
Shenyang 7
Auburn Hills 6
Redwood City 6
Chicago 5
Kocaeli 5
Mountain View 5
Changsha 4
Chengdu 4
Edinburgh 4
Florence 4
Frankfurt am Main 4
Helsinki 4
Indiana 4
Los Angeles 4
Rozzano 4
Warsaw 4
Amsterdam 3
Atlanta 3
Chiswick 3
Dallas 3
Hebei 3
Jinhua 3
Kilburn 3
Parma 3
Ponte Lambro 3
Prescot 3
Shaoxing 3
Toronto 3
Tunja 3
Wuhan 3
Aversa 2
Avezzano 2
Baotou 2
Berlin 2
Bratislava 2
Castellammare di Stabia 2
Charlotte 2
Collecchio 2
Copenhagen 2
Dubai 2
Fagnano Olona 2
Fiorenzuola D'arda 2
Gravina di Catania 2
Hangzhou 2
Lissone 2
Locate Di Triulzi 2
Manchester 2
Maryville 2
Montecchio Maggiore 2
Montreal 2
Québec 2
Redmond 2
Sioux Falls 2
Stezzano 2
Stockholm 2
Strasbourg 2
Taizhou 2
Tianjin 2
Vancouver 2
Totale 7.342
Nome #
LUTEOMA GRAVIDICO CON ASCITE MASSIVA: DESCRIZIONE DI UN CASO 229
Loss of function of Ribonuclease T2, an ancient and phylogenetically conserved RNase, plays a crucial role in ovarian tumorigenesis 224
Microsatellite analysis of sporadic and hereditary gynaecological cancer in routine diagnostics 199
Inherited cancer syndromes in 220 Italian ovarian cancer patients 185
Durable recurrence-free survival after pneumonectomy for late lung metastasis from rectal cancer: Case report with genetic and epigenetic analyses 182
Two Cases of Carcinosarcomas of the Ovary Involved in Hereditary Cancer Syndromes 179
Natural history of cervical intraepithelial neoplasia during pregnancy. 168
Endometrial cancer cells can express fibrinogen: Immunohistochemistry and RT-PCR analysis 167
Carcinosarcoma of the uterine cervix: Case report and discussion. 166
Somatic Testing on Gynecological Cancers Improve the Identification of Lynch Syndrome 162
Microenvironmental control of malignancy exerted by RNASET2, a widely conserved extracellular RNase. 161
Oxidative DNA damage induces hypomethylation in a compromised base excision repair colorectal tumourigenesis 156
Primary Extranodal Marginal Cell Lymphoma, MALT Type, of the Endometrium Arising in a Patient With Rheumatoid Arthritis: Report of a Case 153
Biochemical and immunohistochemical characterization of human RNASET2 expression 146
Renal cell carcinoma metastatic to a pituitary FSH/LH adenoma: Case report and review of the literature 145
null 144
Primary peritoneal cancer in Lynch syndrome: a clinical-pathologic report of a case and analysis of the literature. 143
Immunohistochemical pattern of hMSH2/hMLH1 in familial and sporadic colorectal, gastric, endometrial and ovarian carcinomas with instability in microsatellite sequences 139
Genetic and cytogenetic observations among different types of ovarian tumors are compatible with a progression model underlying ovarian tumorigenesis 138
Androgen receptor is frequently expressed in HER2-positive, ER/PR-negative breast cancers 135
Identifying factors contributing to reduced breast tumor size: A longitudinal study 131
Tumor suppression by means of microenvironment-mediated stress response: the role of the human RNASET2 gene 128
Targeted gene sequencing of Lynch syndrome–related and sporadic endometrial carcinomas 123
Disorders of the Endocrine System 121
Risk factors for cervical intraepithelial neoplasia recurrence after conization: a 10-year study 119
Prevalence of HIV-1 primary drug resistance in seroconverters of the ICoNA cohort over the period 1996-2001 113
Immunohistochemical study of androgen receptors in breast carcinoma. Evidence of their frequent expression in lobular carcinoma. 113
Early Involvement of 6q in Surface Epithelial Ovarian Tumors 113
Diabetic fibrous mastopathy: sonographic-pathologic correlation 107
"Proximal type" epithelioid sarcoma of the vulva: differential diagnosis with other extrarenal rhabdoid tumors 105
Microsatellite instability in endometrial cancer. Relation to histological subtypes 104
Postoperative complications after pelvic lymphadenectomy for the surgical staging of endometrial cancer. 103
Physical map of the D6S149-D6S193 region on chromosome 6Q27 and its involement in benign surface epithelial ovarian tumours 101
RNASET2 expression in ovarian epithelial tumors and clinico-pathological correlations. 100
Inhibition of Sp1-dependent transcription and antitumor activity of the new aureolic acid analogues mithramycin SDK and SK in human ovarian cancer xenografts 99
Fetoplacental cytomegalovirus infection. A case report 98
Clinico-pathological correlations of karyotype analysis in ovarian carcinomas 98
The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas. 98
RNASET2, a human tumor antagonizing gene supressing tumor growth in vivo but not in vitro 97
Prognostic significance of p53, CA19.9 and M3SI expression in ovarian carcinomas 95
Human RNASET2 mediates tumor suppression by means of in vivo recruitment of stromal cells 94
Tumor antagonizing genes and ovarian cancer: the role of the human RNASET2 gene. 93
CD44 expression in ER and PR negative ductal breast carcinomas 93
Intraoperative radioimmunoguided of colo-rectal cancer using monoclonal antibody B72.3 labelled with 125I 93
IMMUNOPHENOTYPIC EVALUATION OF ESTROGEN AND PROGESTERONE RECEPTORS NEGATIVE BREAST CARCINOMAS 90
Chromosome 6 abnormalities in borderline ovarian tumours suggest a genetic continuum in the progression model of ovarian neoplasms. 89
Instabilità dei microsatelliti e perdita dell’espressione della proteina hMLH1 in carcinomi sincroni endometriali e ovarici 87
Carcinoma lobulare in situ e invasivo: studio di clonalità con mtDNA 87
Adenohypophyseal differentiation in ovarian mature cystic teratomas and in ovarian carcinoids 86
6q27 contains candidate genes involved in surface epithelial ovarian tumors. 4th congress of the European Society for Gynecologic and Obstetric Investigation, Madonna di Campiglio, 14-20 marzo, 1999 85
IDENTIFICAZIONE E TIPIZZAZIONE DEI GENOTIPI HPV AD ALTO RISCHIO NELLE LESIONI PRENEOPLASTICHE DELLA CERVICE UTERINA: CORRELAZIONI CLINICOPATOLOGICHE 85
METILAZIONE DE NOVO DI p16, hMLH1 E MGMT NEI CARCINOMI SINCRONI ENDOMETRIALI E OVARICI 85
“Microsatellite instability and lack of hMLH1 expression in synchronous endometrial and ovarian carcinomas” 84
Rnaset2, the first human ribonuclease of the rh/t2/s family, displays a role in tumor suppression 83
Calretinin expression in different molecular subtypes of ER and PR negative breast carcinomas 83
Breast carcinomas with neuroendocrine features are neoplasms of low grade malignancy 83
Microsatellite instability and lack of hMLH1 expression in syncronous endometrial and ovarian carcinomas 83
Chromosome 6 abnormalities in ovarian surface epithelial tumors of borderline malignancy suggest a genetic continuum in the progression model of ovarian neoplasms 82
RNASET2 is a non-cell autonomous human tumor suppressor 82
Androgen receptors in breast 82
Prognostic significance of p53, CA19.9 and M3SI expression in ovarian carcinomas 82
Cellular and molecular consequences of peroxisome proliferator-activated receptor-gamma activation in ovarian cancer cells.Neoplasia 81
The in vivo tumor antagonizing role of human RNASET2 is mediated by host stromal cells recruitment 80
Prognostic significance of karyotype analysis in ovarian carcinomas 80
Immunohistochemical expression and methilation status of MGMT in diffuse large B-cells lymphomas 80
Correlation between microsatellite instability, clinico-pathological and immunohistochemical features in endometrial carcinomas 79
Ovarian retiform Sertoli-Leydig cell tumor : clinicopathological study of a case, 22th Int Meeting of the Adriatic Society of Pathology 79
Pituitary adenomas, a thirty-four-years experience in a –single institution. 79
Clinico - Pathological profile of Estrogen and Progesteron receptors negatibe breast cancinomas with basal or luminal markers expression 78
Ki67, p53 and pttg-1 expression in invasive pituitary adenomas. 77
Instabilità dei microsatelliti e perdita dell'espressione della proteina hMLH1 in carcinomi sincroni endometriali e ovarici 77
Non-chromaffin paraganglioma of the cervix uteri. Immunohistochemical and ultrastructural study 77
Ovarian metastases from colorectal carcinoma. Clinicopathologic profile, immunophenotype, and karyotype analysis 76
Prognostic significance of p53 CA 19-9 and M3SI expression in ovarian carcinomas. 76
Chromosome 6 abnormalities in borderline tumors suggest a genetic continuum in the progression model of ovarian neoplasms 75
Er negative, p53 positive, breast cancers frequently express basal and myoepithelial cell markers 75
Microsatellite instability and lack of hMLH1 expression in synchronous endometrial and ovarian carcinomas 75
Clinicopathological features of oral carcinoma: analysis of 240 cases 74
IL CARCINOMA MICROINVASIVO DELLA CERVICE 72
Ovarian metastases: clinico-pathological profile, immunophenotype and Karyotype analysis 71
p53 positive, breast cancers frequently express basal and myoepithelial cell markers 71
The applications of FISH in tumor pathology 71
PLACENTAL MALARIA AS A CAUSE OF INTRPAUTERINE FETAL DEATH IN ASYMPTOMATIC PATIENT. A CASE REPORT 67
Expression of gastrointestinal markers in pancreatic carcinomas 67
Prognostic significance of karyotype analysis in ovarian carcinomas 66
Frequency and chacterization of anterior pituitary component in ovarian mature cystic teratomas. 66
Molecular genetics of syncronous endometrial and ovarian carcinomas 65
Gestione per processi in anatomia patologica. Strumenti di analisi del rischio di errore. Azioni correttive e di miglioramento 65
Histopathology, hormone products, and clinico-pathologic profile of endocrine tumors of the small intestine. A study of 44 cases. 64
Espressione del recettore degli androgeni nel carcinoma mammario 63
CLINICO-PATHOLOGICAL PROFILE OF ESTROGEN AND PROGESTERONE NEGATIVE BREAST CARCINOMAS WITH BASAL OR LUMINAL MARKERS EXPRESSION 63
LONG-TERM FOLLOW-UP OF IN SITU CARCINOMA OF THE BREAST 62
Correlazioni cisto-isto-colposcopiche in 150 casi consecutivi di patologia cervicale. 61
Classification and histogenesis of gastroenteropancreatic endocrine tumors. 58
ESTROGEN RECEPTOR NEGATIVE INVASIVE BREAST CARCINOMAS FREQUENTLY EXPRESS MYOEPITHELIAL MARKERS 56
Chromosome 6 abnormalities are frequently expressed in Borderline Ovarian Epithelial Tumors suggesting a progression model of ovarian carcinogenesis 54
RNASET2 is the first ribonuclease of the Rh/T2/S family discovered in humans and displays unusual roles in tumor suppression. 52
Genetic similarities and differences between lobular in situ neoplasia (LN) and invasive lobular carcinoma of the breast.Virchows Archiv 51
Ano 50
null 44
Totale 9.975
Categoria #
all - tutte 30.376
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.376


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019496 0 0 0 0 0 0 0 0 0 60 146 290
2019/20201.785 71 65 64 275 77 277 338 226 100 142 25 125
2020/20211.569 19 244 98 165 48 162 50 130 228 65 145 215
2021/20221.054 106 126 96 76 46 37 37 69 53 161 83 164
2022/20231.514 131 103 107 203 92 310 3 210 228 36 63 28
2023/20242.387 409 402 415 428 484 157 9 17 59 7 0 0
Totale 10.405